$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000139681418000025 Filed on August 02, 2018

Income Statement

Concept	2018 Q2	2017 Q2	2012 Q2
Revenue	$84.11M	$70.93M	$12.34M
YoY Change	18.57%	1.86%	239.49%
Cost Of Revenue	$20.92M	$23.81M	$6.685M
YoY Change	-12.16%	3.29%	114.61%
Gross Profit	$63.19M	$47.12M	$5.659M
YoY Change	34.1%	1.15%	986.18%
Gross Profit Margin	75.13%	66.43%	45.84%
Selling, General & Admin	$44.25M	$39.55M	$10.41M
YoY Change	11.88%	-9.43%	133.16%
% of Gross Profit	70.02%	83.93%	184.01%
Research & Development	$12.24M	$18.86M	$1.872M
YoY Change	-35.09%	101.41%	-59.18%
% of Gross Profit	19.37%	40.01%	33.08%
Depreciation & Amortization	$2.800M	$3.700M	$0.00
YoY Change	-24.32%	15.63%	-100.0%
% of Gross Profit	4.43%	7.85%	0.0%
Operating Expenses	$77.57M	$86.71M	$18.97M
YoY Change	-10.55%	13.97%	55.91%
Operating Profit	$6.541M	-$15.78M	-$6.626M
YoY Change	-141.45%	144.88%	-22.33%
Interest Expense	$5.397M	$5.226M	$494.0K
YoY Change	3.27%	201.56%	-26.92%
% of Operating Profit	82.51%
Other Income/Expense, Net	-$3.942M	-$3.933M	-$1.670M
YoY Change	0.23%	170.12%	619.83%
Pretax Income	$2.599M	-$19.71M	-$8.296M
YoY Change	-113.18%	149.53%	-5.73%
Income Tax	$35.00K	$30.00K	$0.00
% Of Pretax Income	1.35%
Net Earnings	$2.564M	-$19.74M	-$8.296M
YoY Change	-112.99%	148.09%	-5.33%
Net Earnings / Revenue	3.05%	-27.83%	-67.21%
Basic Earnings Per Share	$0.06	-$0.49	-$0.27
Diluted Earnings Per Share	$0.06	-$490.0K	-$0.27
COMMON SHARES
Basic Shares Outstanding	40.80M shares	40.16M shares	30.95M shares
Diluted Shares Outstanding	41.69M shares	40.16M shares	30.95M shares

Balance Sheet

Concept	2018 Q2	2017 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$371.3M	$382.4M	$84.30M
YoY Change	-2.9%	135.03%	78.6%
Cash & Equivalents	$116.9M	$53.81M	$21.45M
Short-Term Investments	$254.5M	$328.6M	$62.80M
Other Short-Term Assets	$6.000M	$7.500M	$3.200M
YoY Change	-20.0%	29.31%	-8.57%
Inventory	$42.05M	$33.60M	$9.299M
Prepaid Expenses
Receivables	$35.64M	$27.47M	$3.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$455.1M	$451.0M	$100.1M
YoY Change	0.9%	74.81%	86.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$111.3M	$103.2M	$29.97M
YoY Change	7.78%	3.99%	21.81%
Goodwill	$59.91M	$50.94M	$8.000M
YoY Change	17.61%	19.16%
Intangibles
YoY Change
Long-Term Investments	$15.70M
YoY Change
Other Assets	$692.0K	$572.0K	$600.0K
YoY Change	20.98%	-15.51%	-45.45%
Total Long-Term Assets	$187.6M	$154.8M	$42.78M
YoY Change	21.24%	8.44%	27.69%
TOTAL ASSETS
Total Short-Term Assets	$455.1M	$451.0M	$100.1M
Total Long-Term Assets	$187.6M	$154.8M	$42.78M
Total Assets	$642.7M	$605.7M	$142.9M
YoY Change	6.1%	51.17%	64.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.26M	$10.39M	$400.0K
YoY Change	37.22%	125.23%	-92.16%
Accrued Expenses	$38.43M	$46.76M	$9.300M
YoY Change	-17.8%	21.98%	158.33%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$300.0K	$1.200M
YoY Change			-80.95%
Total Short-Term Liabilities	$53.02M	$57.51M	$15.24M
YoY Change	-7.8%	-61.77%	-12.94%
LONG-TERM LIABILITIES
Long-Term Debt	$283.3M	$269.3M	$25.90M
YoY Change	5.2%		14.6%
Other Long-Term Liabilities	$15.89M	$17.86M	$7.200M
YoY Change	-11.05%	26.1%	-70.12%
Total Long-Term Liabilities	$15.89M	$17.86M	$33.10M
YoY Change	-11.05%	26.1%	-29.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.02M	$57.51M	$15.24M
Total Long-Term Liabilities	$15.89M	$17.86M	$33.10M
Total Liabilities	$352.2M	$344.7M	$48.35M
YoY Change	2.17%	100.0%	-24.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$395.9M	-$386.1M
YoY Change	2.52%	20.63%
Common Stock	$41.00K	$40.00K
YoY Change	2.5%	8.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	1.065K shares
Shareholders Equity	$290.5M	$261.0M	$94.51M
YoY Change
Total Liabilities & Shareholders Equity	$642.7M	$605.7M	$142.9M
YoY Change	6.1%	51.17%	64.06%

Cashflow Statement

Concept	2018 Q2	2017 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$2.564M	-$19.74M	-$8.296M
YoY Change	-112.99%	148.09%	-5.33%
Depreciation, Depletion And Amortization	$2.800M	$3.700M	$0.00
YoY Change	-24.32%	15.63%	-100.0%
Cash From Operating Activities	$13.71M	$3.650M	-$20.22M
YoY Change	275.62%	-51.59%	85.16%
INVESTING ACTIVITIES
Capital Expenditures	-$2.640M	-$5.150M	-$4.370M
YoY Change	-48.74%	-41.94%	261.16%
Acquisitions
YoY Change
Other Investing Activities	$62.21M	-$56.00M	-$43.18M
YoY Change	-211.09%	419.48%	118.52%
Cash From Investing Activities	$59.57M	-$61.15M	-$47.54M
YoY Change	-197.42%	211.35%	126.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$62.90M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.020M	2.330M	64.00M
YoY Change	-13.3%	-2.1%
NET CHANGE
Cash From Operating Activities	13.71M	3.650M	-20.22M
Cash From Investing Activities	59.57M	-61.15M	-47.54M
Cash From Financing Activities	2.020M	2.330M	64.00M
Net Change In Cash	75.30M	-55.17M	-3.760M
YoY Change	-236.49%	467.59%	-88.21%
FREE CASH FLOW
Cash From Operating Activities	$13.71M	$3.650M	-$20.22M
Capital Expenditures	-$2.640M	-$5.150M	-$4.370M
Free Cash Flow	$16.35M	$8.800M	-$15.85M
YoY Change	85.8%	-46.37%	63.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5610000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	16000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-252000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40960416	shares
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	524000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	786000	USD
CY2017Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	130000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	336000	USD
CY2018Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
CY2017Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	186000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	392000	USD
CY2018Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	199000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	400000	USD
CY2017Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5741000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	11658000	USD
CY2018Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	4827000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	11182000	USD
CY2017Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	29000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	83000	USD
CY2018Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	202000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	241000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	284000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2018Q2	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	0	shares
CY2018Q2	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	100000	USD
	pcrx	Deferred Tax Liability Convertible Senior Notes Conversion DeferredTaxLiabilityConvertibleSeniorNotesConversion	26500000	USD
	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	668000	USD
	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	216000	USD
CY2017Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1274000	USD
CY2018Q2	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	902000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	120960000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	59800000	USD
CY2018Q2	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	65200000	USD
	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	4715000	USD
CY2017Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2018Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-2294000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-2032000	USD
CY2017Q2	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2018Q2	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	87000	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2017Q4	pcrx	Investments Contingent Purchase Obligation InvestmentsContingentPurchaseObligation	900000	USD
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	4206000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	4715000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1056000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	952000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	-96000	USD
CY2018Q2	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	35900000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14658000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	14260000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31658000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35641000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41159000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38434000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49210000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54003000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-454000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-545000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	669032000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	686888000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-126326000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15432000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7345000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14744000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7047000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15432000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4362000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6283000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5512000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6320000	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4290000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5610000	shares
CY2017Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	236000	USD
CY2018Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	257000	USD
	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	31000	USD
CY2017Q4	us-gaap	Assets Assets	628371000	USD
CY2018Q2	us-gaap	Assets Assets	642681000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	391110000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6813000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	455054000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	10000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53814000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116871000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40668877	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40954969	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40668877	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40954969	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19725000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39643000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2920000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8207000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1000000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	324000	USD
CY2018Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	330000	USD
CY2017Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	276173000	USD
CY2018Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	283258000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	23811000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	48392000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	20916000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	43801000	USD
	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	36000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1361000	USD
CY2018Q2	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	100000	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10000	shares
CY2017Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0770
CY2018Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2017Q2	us-gaap	Depreciation Depreciation	3700000	USD
	us-gaap	Depreciation Depreciation	6800000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	2800000	USD
	us-gaap	Depreciation Depreciation	5600000	USD
CY2017Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1510000	USD
CY2018Q2	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1159000	USD
CY2017Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4495000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4495000	USD
CY2018Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-162000	USD
CY2018Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	300000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	699000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.01
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2030000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2018Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	55197000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	59912000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18950000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-38269000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	592000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9221000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19713000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39549000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2599000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8046000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-763000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1280000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2007000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1175000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	133000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	146000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2149000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2826000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2470000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3640000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8402000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2303000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2324000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1849000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-102000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	642000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1480000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	325000	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	4000	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	807000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2018Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	5226000	USD
	us-gaap	Interest Expense InterestExpense	7815000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	5397000	USD
	us-gaap	Interest Expense InterestExpense	10553000	USD
	us-gaap	Interest Paid InterestPaid	2384000	USD
	us-gaap	Interest Paid InterestPaid	4102000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16540000	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	18652000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	41411000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	42053000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16500000	USD
CY2018Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16070000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8371000	USD
CY2018Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7331000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1224000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1738000	USD
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1533000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2906000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	348888000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	352168000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	628371000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	642681000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56217000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	53024000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	60047000	USD
CY2018Q2	us-gaap	Long Term Investments LongTermInvestments	1601000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	17870000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	62745000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	219194000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2444000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-204986000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	49280000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3662000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11021000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39609000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-19743000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3933000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9720000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3942000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7651000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	86714000	USD
	us-gaap	Operating Expenses OperatingExpenses	170046000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77566000	USD
	us-gaap	Operating Expenses OperatingExpenses	159109000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15780000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29829000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6541000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-395000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	49847000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5366000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5245000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7604000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8122000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	19577000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3933000	USD
	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	80000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	825000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	692000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	18000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-34000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	356000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-91000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	18000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-34000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	356000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-91000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16498000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15886000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	80000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-78000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8771000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7818000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	274791000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	182749000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6694000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6039000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	82782000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	244562000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2613000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1492000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156256000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	165279000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107046000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	111276000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	118191000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18856000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35487000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12239000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26617000	USD
CY2017Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1389000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	2611000	USD
CY2018Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1819000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	3609000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-389136000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-395871000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70139000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	138564000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80717000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	155004000	USD
CY2017Q2	us-gaap	Revenues Revenues	70934000	USD
	us-gaap	Revenues Revenues	140217000	USD
CY2018Q2	us-gaap	Revenues Revenues	84107000	USD
	us-gaap	Revenues Revenues	158714000	USD
CY2017Q2	us-gaap	Royalty Revenue RoyaltyRevenue	665000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1317000	USD
CY2018Q2	us-gaap	Royalty Revenue RoyaltyRevenue	390000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	710000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	70139000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	138564000	USD
CY2018Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	80717000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	155004000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39552000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81672000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44249000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	88439000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7345000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14744000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7047000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15432000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.85
CY2018Q2	us-gaap	Share Price SharePrice	32.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	257221000	USD
CY2018Q2	us-gaap	Short Term Investments ShortTermInvestments	254450000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	34985	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	952000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1492000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	290513000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14000000	USD
CY2018Q2	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	76000	USD
CY2018Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2018Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40160000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39079000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41694000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40751000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40160000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39079000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40796000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40751000	shares

Files In Submission

Name	View Source	Status
0001396814-18-000025-index-headers.html	Edgar Link	pending
0001396814-18-000025-index.html	Edgar Link	pending
0001396814-18-000025.txt	Edgar Link	pending
0001396814-18-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
paciralogoa12.jpg	Edgar Link	pending
pcrx-20180630.xml	Edgar Link	completed
pcrx-20180630.xsd	Edgar Link	pending
pcrx-20180630_cal.xml	Edgar Link	unprocessable
pcrx-20180630_def.xml	Edgar Link	unprocessable
pcrx-20180630_lab.xml	Edgar Link	unprocessable
pcrx-20180630_pre.xml	Edgar Link	unprocessable
pcrx-6302018x10xq.htm	Edgar Link	pending
pcrx-6302018xex101.htm	Edgar Link	pending
pcrx-6302018xex102.htm	Edgar Link	pending
pcrx-6302018xex311.htm	Edgar Link	pending
pcrx-6302018xex312.htm	Edgar Link	pending
pcrx-6302018xex321.htm	Edgar Link	pending
pcrx-6302018xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2018 Q2 Form 10-Q Financial Statement

#000139681418000025 Filed on August 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2018 Q2 Form 10-Q Financial Statement

#000139681418000025 Filed on August 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx